Hypoalphalipoproteinemia (low high density lipoprotein) as a risk factor for coronary heart disease

Current Opinion in Lipidology

Volumn 7, Issue 4, 1996, Pages 209-216

  Vega, Gloria Lena ^a,b   Grundy, Scott M ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL ESTER TRANSFER PROTEIN; CHYLOMICRON; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL LIPASE; VERY LOW DENSITY LIPOPROTEIN;

CORONARY RISK; DIABETES MELLITUS; ENDOTHELIUM; HUMAN; HYPERTENSION; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 0029766905     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199608000-00007     Document Type: Review

References (25)

1. Matsunaga T, Hiasa Y, Yanagi H, Maeda T, Hattori N, Yamakawa K, Yamanouchi Y, Tinaka I, Obara T, Hamagouchi H: Apolipoprotein A-I deficiency due to a codon 84 nonsense mutation of the apolipoprotein A-I gene. Proc Natl Acad Sci U S A 1991, 88:2793-2797.
2. Ng DS, Leiter LA, Vezina C, Connelly PW, Hegele RA: Apolipoprotein A-I O[-2]X causing isolated apolipoprotein A-I deficiency in a family with analphalipoproteinemia. J Clin Invest 1994, 93:223-229.
3. Roming R, von Eckardstein A, Funke H, Motti C, Fragiacomo GC, Noseda G, Assman G: A nonsense mutation in the apolipoprotein A-I gene is associated with high-density lipoprotein deficiency and periorbital xanthelasmas. Arterioscl Thromb 1994, 14:1915-1992.
4. Takata K, Saku K, Ohta T, Takala M, Bai H, Jimi S, Liu R, Sato H, Kajiyama G, Arakawa K: A new case of apo A-I deficiency showing codon 8 nonsense mutation of the apo A-I gene without evidence of coronary heart disease. Arterioscl Thromb Vasc Biol 1995, 15:1866-1874.
5. Tilly-Kiesi M, Zhang Q, Ehnholm S, Kahri J, Lahdependera S, Ehnholm C, Taskinnen MR: Apo A-I Helsinki (Lys 107-0) associated with reduced HDL cholesterol and LpA-I: A-II deficiency. Arterioscl Thromb Vase Biol 1995, 15:1294-1306.
6. Ikewaki K, Nishiwaki M, Samamoto T, Ishikawa T, Fairwell T, Zech LA, Nagano M, Nakamura H, Brewer HB Jr, Radar DJ: Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency. J Clin Invest 1995, 96:1573-1581.
7. Tato F, Vega GL, Grundy SM: Bimodal distribution of cholesteryl ester transfer protein activities in normotriglyceridemic men with low HDL cholesterolconcentrations. Arterioscl Thromb Vasc Biol 1995, 15:446-451.
8. Blades B, Vega GL, Grundy SM: Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol. Arterioscl Thromb 1993, 13: 1227-1235.
9. Cohen JC, Wang Z, Grundy SM, Stoesz MR, Guerra R: Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels. J Clin Invest 1994, 94:2377-2384.
10. Mahley RW, Palauglu KE, Atak Z, Dawson-Pepin J, Langlois AM, Cheung V, Onat H, Fulks P, Mahlery LL, Vakar F et al.: The Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J Lipid Res 1995, 36:839-859.
11. Rubin EM, Krauss RM, Spangler AE, Verstuyft JG, Clift SM: Inhibition of early atherogenesis in transgenic mice by human apolipoprotein A-I. Nature 1993, 365:265-267.
12. Warden CH, Hedrick CC, Qiao J-H, Castellani LW, Lusis AJ: Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. Science 1993, 261:469-472.
13. Plump AS, Scott CJ, Breslow JL: Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosisin the apolipoprotein E-deficient mouse. Proc Natl Acad Sci U S A 1994, 91:9607-9611.
14. Li H, Reddick RL, Maeda N: Lack of apo A-I is not associated with increased susceptibility to atherosclerosis in mice. Arterioscl Thromb 1993, 13:1814-1821.
15. Maroni KR, Castle CK, Boyle TP, Lin AH, Murray RW, Melchior GW: Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature 1993, 364:73-75.
16. Hayek T, Masucci-Magoulas L, Jiang X, Walsh A, Rubin E, Breslow JL, Tall AR: Decreased early atherosclerosic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene. J Clin Invest 1995, 96:2071-2074.
17. Austin MA: Plasma triglyceride and coronary heart disease. Arterioscl Thromb 1991, 11:2-14.
18. Pastch JR, Carlin JB. Scott LW, Smith LC, Gotto AM Jr: Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic Lipase. J Clin Invest 1983, 80:341-347.
19. Cohen JC, Stray-Gundersen J, Grundy SM: Dissociation between postprandial lipemia and high density lipoprotein cholesterol concentrations in endurance-trained men. Arterioscl Thromb 1991, 11:838-843.
20. Cohen JC, Grundy SM: Normal post-prandial lipidemia in men with low plasma HDL concentrations. Arterioscl Thromb 1992, 12:972-975.
21. Vega GL, Grundy SM: Two patterns of LDL metabolism in normotrigly ceridemic patients with hypoalphalipoproteinemia. Arterioscl Thromb 1993, 13:579-589.
22. Abate N, Vega GL, Grundy SM: Variability in cholesterol content and physical properties of lipoproteins containing apolipoprotein B-100. Atherosclerosis 1993, 104:159-171.
23. Gordon DJ, Probostifield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs DR Jr, Bangdiwala S, Tyroler HA: High-density lipoprotein and cardiovascular disease: four American studies. Circulation 1989, 79:8-15.
24. Karhapaa P, Malkki M, Laakso M: Isolated low HDL cholesterol, an insulin-resistant state. Diabetes 1994, 43:411-417.
25. Abate N, Vega GL, Garg A, Grundy SM: Abnormal cholesterol distribution among lipoprotein fractions in normolipidemic patients with mild NIDDM. Atherosclerosis 1995, 118:111-122.